Neil King

Seattle, Washington, USA

Recent coverage

Front-page news, podcasts and videos about Neil

See all 12

Trump-Era Funding Cuts and Hiring Freeze Stall UW Protein Design Startups Led by Nobel Laureate David Baker

The University of Washington's Institute for Protein Design, led by Nobel laureate David Baker, faces a hiring freeze and funding cuts under the Trump administration, stalling its promising protein design startups and reducing opportunities for graduate students and postdocs. Despite Nobel-driven interest and advances in AI-designed proteins, budget constraints threaten future innovation and company spinoffs.

AstraZeneca to Acquire UW Spinout Icosavax for Up to $1.1 Billion to Boost Respiratory Vaccine Development

AstraZeneca announced it will acquire Seattle-based biotech spinout Icosavax, founded at the University of Washington, for up to $1.1 billion to accelerate development of vaccines targeting respiratory viruses. Icosavax's shares surged over 40% after the deal, which values the company at a 43% premium and aims to advance its lead RSV and hMPV vaccine candidate.

Organizations

Questions about Neil King

Who is Neil King?

Neil King is a researcher at Institute for Protein Design and an associate professor at Institute for Protein Design, UW Medicine. Neil was previously scientific co-founder at Icosavax.

What is Neil King known for?

Neil King is known for academic work in protein design and as scientific co-founder of Icosavax.

Which organizations is Neil King associated with?

Neil King is associated with Institute for Protein Design as a current researcher and Institute for Protein Design, UW Medicine as a current associate professor. Neil was previously scientific co-founder at Icosavax.

Where is Neil King based?

Neil King is based in Seattle, Washington, USA.